

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 8.95745910 |
| 2 | drug transport (GO:0015893) | 8.69390689 |
| 3 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 8.67221363 |
| 4 | lysine catabolic process (GO:0006554) | 8.46726050 |
| 5 | lysine metabolic process (GO:0006553) | 8.46726050 |
| 6 | organic cation transport (GO:0015695) | 8.19334391 |
| 7 | phosphate ion transport (GO:0006817) | 7.79380394 |
| 8 | regulation of guanylate cyclase activity (GO:0031282) | 7.62260427 |
| 9 | lipoprotein transport (GO:0042953) | 6.99936222 |
| 10 | intestinal absorption (GO:0050892) | 6.79535669 |
| 11 | phosphate ion transmembrane transport (GO:0035435) | 6.74381558 |
| 12 | cysteine metabolic process (GO:0006534) | 6.62146457 |
| 13 | epoxygenase P450 pathway (GO:0019373) | 6.59824393 |
| 14 | quaternary ammonium group transport (GO:0015697) | 6.42731387 |
| 15 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.40769123 |
| 16 | drug catabolic process (GO:0042737) | 6.40043539 |
| 17 | glyoxylate metabolic process (GO:0046487) | 6.12413924 |
| 18 | exogenous drug catabolic process (GO:0042738) | 5.98135698 |
| 19 | regulation of bile acid biosynthetic process (GO:0070857) | 5.96034328 |
| 20 | excretion (GO:0007588) | 5.93148947 |
| 21 | response to mercury ion (GO:0046689) | 5.83646527 |
| 22 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.79661887 |
| 23 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.75625353 |
| 24 | renal absorption (GO:0070293) | 5.74699266 |
| 25 | aspartate family amino acid catabolic process (GO:0009068) | 5.52026918 |
| 26 | tricarboxylic acid metabolic process (GO:0072350) | 5.51489710 |
| 27 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.49717173 |
| 28 | endocrine process (GO:0050886) | 5.49717173 |
| 29 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.49717173 |
| 30 | hormone catabolic process (GO:0042447) | 5.44603566 |
| 31 | short-chain fatty acid metabolic process (GO:0046459) | 5.31232793 |
| 32 | glutathione biosynthetic process (GO:0006750) | 5.30722353 |
| 33 | vitamin D metabolic process (GO:0042359) | 5.20746898 |
| 34 | homocysteine metabolic process (GO:0050667) | 5.19177691 |
| 35 | metanephric nephron tubule development (GO:0072234) | 5.13989123 |
| 36 | metanephric tubule development (GO:0072170) | 5.13989123 |
| 37 | toxin transport (GO:1901998) | 5.08524472 |
| 38 | modified amino acid transport (GO:0072337) | 5.06519171 |
| 39 | regulation of cellular extravasation (GO:0002691) | 4.96944999 |
| 40 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.96864696 |
| 41 | regulation of systemic arterial blood pressure (GO:0003073) | 4.96400967 |
| 42 | branched-chain amino acid metabolic process (GO:0009081) | 4.88843387 |
| 43 | diacylglycerol metabolic process (GO:0046339) | 4.88781143 |
| 44 | carnitine transport (GO:0015879) | 4.87463711 |
| 45 | amino-acid betaine transport (GO:0015838) | 4.87463711 |
| 46 | virion attachment to host cell (GO:0019062) | 4.81806465 |
| 47 | adhesion of symbiont to host cell (GO:0044650) | 4.81806465 |
| 48 | valine metabolic process (GO:0006573) | 4.80820132 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 4.79606435 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 4.79606435 |
| 51 | tryptophan catabolic process (GO:0006569) | 4.79606435 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 4.74758222 |
| 53 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.74202433 |
| 54 | metanephric nephron epithelium development (GO:0072243) | 4.71132093 |
| 55 | 2-oxoglutarate metabolic process (GO:0006103) | 4.70704954 |
| 56 | trivalent inorganic anion homeostasis (GO:0072506) | 4.69847336 |
| 57 | phosphate ion homeostasis (GO:0055062) | 4.69847336 |
| 58 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.69293321 |
| 59 | aromatic amino acid family catabolic process (GO:0009074) | 4.65289334 |
| 60 | cellular glucuronidation (GO:0052695) | 4.62979748 |
| 61 | regulation of cGMP biosynthetic process (GO:0030826) | 4.62512539 |
| 62 | uronic acid metabolic process (GO:0006063) | 4.57177020 |
| 63 | glucuronate metabolic process (GO:0019585) | 4.57177020 |
| 64 | plasma lipoprotein particle assembly (GO:0034377) | 4.55823393 |
| 65 | tryptophan metabolic process (GO:0006568) | 4.50540420 |
| 66 | peptide hormone processing (GO:0016486) | 4.45090854 |
| 67 | L-phenylalanine metabolic process (GO:0006558) | 4.42667098 |
| 68 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.42667098 |
| 69 | bile acid and bile salt transport (GO:0015721) | 4.36635299 |
| 70 | urea cycle (GO:0000050) | 4.36313056 |
| 71 | renal system process involved in regulation of blood volume (GO:0001977) | 4.36151842 |
| 72 | amino-acid betaine metabolic process (GO:0006577) | 4.36111338 |
| 73 | cellular modified amino acid catabolic process (GO:0042219) | 4.34078160 |
| 74 | L-phenylalanine catabolic process (GO:0006559) | 4.33679063 |
| 75 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.33679063 |
| 76 | metanephric epithelium development (GO:0072207) | 4.29312584 |
| 77 | fatty acid beta-oxidation (GO:0006635) | 4.29280740 |
| 78 | glycoside metabolic process (GO:0016137) | 4.23510371 |
| 79 | fructose metabolic process (GO:0006000) | 4.22883912 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 4.22383556 |
| 81 | response to phenylpropanoid (GO:0080184) | 4.21849789 |
| 82 | peptide biosynthetic process (GO:0043043) | 4.21317570 |
| 83 | serine family amino acid catabolic process (GO:0009071) | 4.20774116 |
| 84 | cellular ketone body metabolic process (GO:0046950) | 4.19700930 |
| 85 | proline metabolic process (GO:0006560) | 4.18192086 |
| 86 | urea metabolic process (GO:0019627) | 4.17872653 |
| 87 | peptide catabolic process (GO:0043171) | 4.17811653 |
| 88 | protein-lipid complex assembly (GO:0065005) | 4.16325051 |
| 89 | regulation of vitamin metabolic process (GO:0030656) | 4.14130618 |
| 90 | adhesion of symbiont to host (GO:0044406) | 4.11985924 |
| 91 | acetyl-CoA metabolic process (GO:0006084) | 4.09230531 |
| 92 | carnitine metabolic process (GO:0009437) | 4.05234934 |
| 93 | glycolipid catabolic process (GO:0019377) | 4.03910741 |
| 94 | glycosphingolipid catabolic process (GO:0046479) | 4.01554796 |
| 95 | nephron tubule development (GO:0072080) | 4.00243896 |
| 96 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.99822574 |
| 97 | fatty acid oxidation (GO:0019395) | 3.99708548 |
| 98 | antibacterial humoral response (GO:0019731) | 3.97589716 |
| 99 | branched-chain amino acid catabolic process (GO:0009083) | 3.94125182 |
| 100 | lipid oxidation (GO:0034440) | 3.91893610 |
| 101 | glutamate metabolic process (GO:0006536) | 3.91566523 |
| 102 | antimicrobial humoral response (GO:0019730) | 3.86855791 |
| 103 | vitamin A metabolic process (GO:0006776) | 3.86612366 |
| 104 | vitamin transmembrane transport (GO:0035461) | 3.85764569 |
| 105 | oligosaccharide catabolic process (GO:0009313) | 3.84614859 |
| 106 | nitrogen cycle metabolic process (GO:0071941) | 3.84396865 |
| 107 | kynurenine metabolic process (GO:0070189) | 3.84366238 |
| 108 | regulation of cGMP metabolic process (GO:0030823) | 3.83643900 |
| 109 | vitamin transport (GO:0051180) | 3.82721936 |
| 110 | sulfur compound transport (GO:0072348) | 3.81696580 |
| 111 | cellular response to nitric oxide (GO:0071732) | 3.81029184 |
| 112 | sulfur amino acid catabolic process (GO:0000098) | 3.76232793 |
| 113 | phospholipid efflux (GO:0033700) | 3.74948192 |
| 114 | lipoprotein metabolic process (GO:0042157) | 3.73806035 |
| 115 | positive regulation of pseudopodium assembly (GO:0031274) | 3.72992389 |
| 116 | polyol transport (GO:0015791) | 3.72404428 |
| 117 | NADH metabolic process (GO:0006734) | 3.67192677 |
| 118 | * digestion (GO:0007586) | 3.66101043 |
| 119 | alkaloid metabolic process (GO:0009820) | 3.63124171 |
| 120 | drinking behavior (GO:0042756) | 3.62313595 |
| 121 | regulation of cholesterol esterification (GO:0010872) | 3.60908931 |
| 122 | ketone body metabolic process (GO:1902224) | 3.60826390 |
| 123 | glutathione metabolic process (GO:0006749) | 3.59069988 |
| 124 | renal tubule development (GO:0061326) | 3.57008605 |
| 125 | response to growth hormone (GO:0060416) | 3.56733647 |
| 126 | fatty acid catabolic process (GO:0009062) | 3.54727323 |
| 127 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.52795508 |
| 128 | cellular amino acid catabolic process (GO:0009063) | 3.52649954 |
| 129 | fat-soluble vitamin metabolic process (GO:0006775) | 3.50541481 |
| 130 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.46733391 |
| 131 | glutathione derivative metabolic process (GO:1901685) | 3.46516323 |
| 132 | glutathione derivative biosynthetic process (GO:1901687) | 3.46516323 |
| 133 | serine family amino acid biosynthetic process (GO:0009070) | 3.45259020 |
| 134 | aromatic amino acid family metabolic process (GO:0009072) | 3.41874288 |
| 135 | cGMP-mediated signaling (GO:0019934) | 3.39874547 |
| 136 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.38771012 |
| 137 | indole-containing compound metabolic process (GO:0042430) | 3.38659136 |
| 138 | alpha-amino acid catabolic process (GO:1901606) | 3.35552083 |
| 139 | drug metabolic process (GO:0017144) | 3.34603688 |
| 140 | transepithelial transport (GO:0070633) | 3.34378162 |
| 141 | response to nitric oxide (GO:0071731) | 3.34320795 |
| 142 | indolalkylamine metabolic process (GO:0006586) | 3.33994212 |
| 143 | regulation of pseudopodium assembly (GO:0031272) | 3.33544036 |
| 144 | digestive system process (GO:0022600) | 3.33258555 |
| 145 | sulfate transmembrane transport (GO:1902358) | 3.33083088 |
| 146 | positive regulation of lipid catabolic process (GO:0050996) | 3.32729043 |
| 147 | flavonoid metabolic process (GO:0009812) | 3.32023927 |
| 148 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.31805111 |
| 149 | cellular response to reactive nitrogen species (GO:1902170) | 3.31791958 |
| 150 | sodium ion transport (GO:0006814) | 3.31248984 |
| 151 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.30220502 |
| 152 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.30220502 |
| 153 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.28738588 |
| 154 | bile acid metabolic process (GO:0008206) | 3.28085443 |
| 155 | monocarboxylic acid catabolic process (GO:0072329) | 3.27532267 |
| 156 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.27273837 |
| 157 | regulation of cholesterol homeostasis (GO:2000188) | 3.26178352 |
| 158 | benzene-containing compound metabolic process (GO:0042537) | 3.25531156 |
| 159 | organic acid catabolic process (GO:0016054) | 3.24909585 |
| 160 | carboxylic acid catabolic process (GO:0046395) | 3.24909585 |
| 161 | cGMP biosynthetic process (GO:0006182) | 3.23962659 |
| 162 | ceramide catabolic process (GO:0046514) | 3.22862851 |
| 163 | sexual reproduction (GO:0019953) | 3.21773207 |
| 164 | succinate metabolic process (GO:0006105) | 3.21618164 |
| 165 | sodium-independent organic anion transport (GO:0043252) | 3.21478289 |
| 166 | nephron epithelium development (GO:0072009) | 3.21042047 |
| 167 | arginine metabolic process (GO:0006525) | 3.19260159 |
| 168 | glycosylceramide metabolic process (GO:0006677) | 3.19048254 |
| 169 | actin filament depolymerization (GO:0030042) | 3.17879304 |
| 170 | neurotransmitter biosynthetic process (GO:0042136) | 3.17223723 |
| 171 | tricarboxylic acid cycle (GO:0006099) | 3.17127071 |
| 172 | glycerol metabolic process (GO:0006071) | 3.17068275 |
| 173 | vitamin biosynthetic process (GO:0009110) | 3.17036052 |
| 174 | transcytosis (GO:0045056) | 3.16716737 |
| 175 | biotin metabolic process (GO:0006768) | 3.16370768 |
| 176 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.16227229 |
| 177 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.14013427 |
| 178 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.13563950 |
| 179 | sphingomyelin metabolic process (GO:0006684) | 3.10789138 |
| 180 | sphingolipid catabolic process (GO:0030149) | 3.09278603 |
| 181 | midgut development (GO:0007494) | 3.08596314 |
| 182 | cobalamin metabolic process (GO:0009235) | 3.08487414 |
| 183 | positive regulation of respiratory burst (GO:0060267) | 3.07286719 |
| 184 | high-density lipoprotein particle remodeling (GO:0034375) | 3.05372774 |
| 185 | plasma lipoprotein particle organization (GO:0071827) | 3.01911248 |
| 186 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.01245513 |
| 187 | angiotensin maturation (GO:0002003) | 11.1197981 |
| 188 | drug transmembrane transport (GO:0006855) | 10.1766070 |
| 189 | urate metabolic process (GO:0046415) | 10.1416278 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.57069663 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.74525774 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.14132834 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.87803158 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.62699427 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.50001466 |
| 7 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.03552087 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.97100759 |
| 9 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.66468669 |
| 10 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.62146038 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.60218690 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.59288621 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.53763184 |
| 14 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.45499633 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.37795104 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.36451333 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.33612189 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.25072919 |
| 19 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.24855004 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.22175682 |
| 21 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.18756909 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 2.17019197 |
| 23 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.94792052 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.93498225 |
| 25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.92789967 |
| 26 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.92506352 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.90528189 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81586202 |
| 29 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.78935910 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.76035829 |
| 31 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.72469251 |
| 32 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.71674734 |
| 33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.71274415 |
| 34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.69780301 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.66888744 |
| 36 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.58711324 |
| 37 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.57763473 |
| 38 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.57143793 |
| 39 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.56837544 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.56284666 |
| 41 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.55723118 |
| 42 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.55406941 |
| 43 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46383531 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.46239584 |
| 45 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.45952113 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44168708 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40323766 |
| 48 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.39121507 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37146843 |
| 50 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.37052720 |
| 51 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35517973 |
| 52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.31419000 |
| 53 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.29108292 |
| 54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28725050 |
| 55 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.21773405 |
| 56 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16445925 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14560297 |
| 58 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14399123 |
| 59 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14287971 |
| 60 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.14139723 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13000687 |
| 62 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11587162 |
| 63 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.11133838 |
| 64 | RXR_22108803_ChIP-Seq_LS180_Human | 1.10799828 |
| 65 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09952661 |
| 66 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.09777990 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09463139 |
| 68 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.08502249 |
| 69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08364066 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08246741 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07869820 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07196882 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05650972 |
| 74 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.04197602 |
| 75 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.04197602 |
| 76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01728208 |
| 77 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.99986412 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99371565 |
| 79 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97542048 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95789670 |
| 81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95457410 |
| 82 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95327689 |
| 83 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95268619 |
| 84 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.93453189 |
| 85 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92974826 |
| 86 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.92649576 |
| 87 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92518532 |
| 88 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.92239923 |
| 89 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91430376 |
| 90 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90774260 |
| 91 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.89515428 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88977509 |
| 93 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.88774997 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88530377 |
| 95 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88483072 |
| 96 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88165669 |
| 97 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.86800360 |
| 98 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86151191 |
| 99 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.85777751 |
| 100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.85302183 |
| 101 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.85237599 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.85137248 |
| 103 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.85013886 |
| 104 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84816484 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84513659 |
| 106 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.84250817 |
| 107 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83077697 |
| 108 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81971357 |
| 109 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81603825 |
| 110 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81293068 |
| 111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80126391 |
| 112 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79958663 |
| 113 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.79828722 |
| 114 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.79179028 |
| 115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79058475 |
| 116 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78930096 |
| 117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78828286 |
| 118 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.78757736 |
| 119 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.77921212 |
| 120 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.77334363 |
| 121 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.77329561 |
| 122 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76515995 |
| 123 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.75943490 |
| 124 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.75351800 |
| 125 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75088309 |
| 126 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.74948919 |
| 127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.74471362 |
| 128 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.73650276 |
| 129 | ATF3_27146783_Chip-Seq_COLON_Human | 0.73241251 |
| 130 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.72893355 |
| 131 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.72818580 |
| 132 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.72679432 |
| 133 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.71241366 |
| 134 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71115171 |
| 135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71115171 |
| 136 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.70626923 |
| 137 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.69893072 |
| 138 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69100614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.53477678 |
| 2 | MP0004043_abnormal_pH_regulation | 6.21379587 |
| 3 | MP0004019_abnormal_vitamin_homeostasis | 4.71120408 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.40699636 |
| 5 | * MP0005332_abnormal_amino_acid | 4.38318538 |
| 6 | MP0003183_abnormal_peptide_metabolism | 4.33715781 |
| 7 | MP0009643_abnormal_urine_homeostasis | 3.86875274 |
| 8 | MP0003195_calcinosis | 3.85100152 |
| 9 | MP0009379_abnormal_foot_pigmentation | 3.73990100 |
| 10 | MP0001765_abnormal_ion_homeostasis | 3.67579045 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 3.63066640 |
| 12 | MP0009840_abnormal_foam_cell | 3.60582995 |
| 13 | MP0005377_hearing/vestibular/ear_phenot | 3.28485719 |
| 14 | MP0003878_abnormal_ear_physiology | 3.28485719 |
| 15 | MP0001756_abnormal_urination | 3.03920968 |
| 16 | MP0005636_abnormal_mineral_homeostasis | 3.00766198 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.98594397 |
| 18 | MP0002136_abnormal_kidney_physiology | 2.82268965 |
| 19 | MP0005365_abnormal_bile_salt | 2.59963266 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 2.58868382 |
| 21 | MP0003252_abnormal_bile_duct | 2.57132898 |
| 22 | * MP0010155_abnormal_intestine_physiology | 2.47298765 |
| 23 | MP0001958_emphysema | 2.29289775 |
| 24 | MP0005409_darkened_coat_color | 2.25751508 |
| 25 | MP0001666_abnormal_nutrient_absorption | 1.83012528 |
| 26 | MP0000490_abnormal_crypts_of | 1.81637206 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.81156444 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.79468652 |
| 29 | MP0010352_gastrointestinal_tract_polyps | 1.79443973 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.78536268 |
| 31 | MP0008961_abnormal_basal_metabolism | 1.69000979 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.62606021 |
| 33 | MP0004264_abnormal_extraembryonic_tissu | 1.61108504 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51314146 |
| 35 | MP0004885_abnormal_endolymph | 1.48938007 |
| 36 | MP0005084_abnormal_gallbladder_morpholo | 1.48591957 |
| 37 | MP0001188_hyperpigmentation | 1.45361771 |
| 38 | MP0003186_abnormal_redox_activity | 1.40873904 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.32898699 |
| 40 | MP0004147_increased_porphyrin_level | 1.32598541 |
| 41 | MP0003283_abnormal_digestive_organ | 1.31967809 |
| 42 | MP0005319_abnormal_enzyme/_coenzyme | 1.31782342 |
| 43 | MP0005451_abnormal_body_composition | 1.28377026 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.22425191 |
| 45 | MP0004270_analgesia | 1.16706689 |
| 46 | MP0000230_abnormal_systemic_arterial | 1.16427558 |
| 47 | MP0000462_abnormal_digestive_system | 1.15114379 |
| 48 | MP0004782_abnormal_surfactant_physiolog | 1.12920584 |
| 49 | MP0003718_maternal_effect | 1.10902367 |
| 50 | MP0002928_abnormal_bile_duct | 1.08551562 |
| 51 | MP0002822_catalepsy | 1.08251463 |
| 52 | MP0002168_other_aberrant_phenotype | 1.05800594 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.05770048 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.04973279 |
| 55 | MP0005448_abnormal_energy_balance | 1.00667305 |
| 56 | MP0002089_abnormal_postnatal_growth/wei | 0.96785512 |
| 57 | * MP0000538_abnormal_urinary_bladder | 0.96336715 |
| 58 | MP0001764_abnormal_homeostasis | 0.96250760 |
| 59 | MP0002971_abnormal_brown_adipose | 0.95945873 |
| 60 | * MP0002135_abnormal_kidney_morphology | 0.94603250 |
| 61 | MP0002118_abnormal_lipid_homeostasis | 0.92108740 |
| 62 | MP0002896_abnormal_bone_mineralization | 0.91430008 |
| 63 | MP0005666_abnormal_adipose_tissue | 0.87050572 |
| 64 | MP0010329_abnormal_lipoprotein_level | 0.86817469 |
| 65 | MP0002796_impaired_skin_barrier | 0.85725910 |
| 66 | MP0003638_abnormal_response/metabolism_ | 0.83024251 |
| 67 | MP0009115_abnormal_fat_cell | 0.82300109 |
| 68 | * MP0001845_abnormal_inflammatory_respons | 0.80018836 |
| 69 | MP0000537_abnormal_urethra_morphology | 0.79260793 |
| 70 | MP0005670_abnormal_white_adipose | 0.79012801 |
| 71 | MP0009785_altered_susceptibility_to | 0.78600457 |
| 72 | MP0001663_abnormal_digestive_system | 0.77130587 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 0.72813061 |
| 74 | MP0003724_increased_susceptibility_to | 0.72390343 |
| 75 | * MP0009642_abnormal_blood_homeostasis | 0.71565225 |
| 76 | MP0002396_abnormal_hematopoietic_system | 0.71564600 |
| 77 | MP0002166_altered_tumor_susceptibility | 0.69923037 |
| 78 | MP0000609_abnormal_liver_physiology | 0.69317529 |
| 79 | MP0001661_extended_life_span | 0.68647411 |
| 80 | MP0003866_abnormal_defecation | 0.67882589 |
| 81 | MP0000604_amyloidosis | 0.67081778 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 0.66543518 |
| 83 | MP0003959_abnormal_lean_body | 0.66472668 |
| 84 | * MP0005535_abnormal_body_temperature | 0.62767298 |
| 85 | MP0005381_digestive/alimentary_phenotyp | 0.62495831 |
| 86 | MP0001835_abnormal_antigen_presentation | 0.62375028 |
| 87 | MP0005025_abnormal_response_to | 0.62213894 |
| 88 | MP0006082_CNS_inflammation | 0.61826504 |
| 89 | MP0003303_peritoneal_inflammation | 0.61798911 |
| 90 | MP0000249_abnormal_blood_vessel | 0.61468900 |
| 91 | MP0001664_abnormal_digestion | 0.60044403 |
| 92 | MP0003646_muscle_fatigue | 0.59766298 |
| 93 | MP0003436_decreased_susceptibility_to | 0.59714600 |
| 94 | MP0005501_abnormal_skin_physiology | 0.59274266 |
| 95 | MP0003879_abnormal_hair_cell | 0.58662685 |
| 96 | MP0009764_decreased_sensitivity_to | 0.58273339 |
| 97 | MP0005395_other_phenotype | 0.56565433 |
| 98 | MP0005220_abnormal_exocrine_pancreas | 0.56512515 |
| 99 | MP0003315_abnormal_perineum_morphology | 0.56333592 |
| 100 | MP0009333_abnormal_splenocyte_physiolog | 0.55686503 |
| 101 | MP0004947_skin_inflammation | 0.54913623 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.54169097 |
| 103 | MP0001485_abnormal_pinna_reflex | 0.52861614 |
| 104 | MP0005174_abnormal_tail_pigmentation | 0.52803420 |
| 105 | MP0003705_abnormal_hypodermis_morpholog | 0.52704449 |
| 106 | MP0005334_abnormal_fat_pad | 0.51684377 |
| 107 | MP0001881_abnormal_mammary_gland | 0.50442772 |
| 108 | MP0005387_immune_system_phenotype | 0.50390900 |
| 109 | MP0001790_abnormal_immune_system | 0.50390900 |
| 110 | MP0000566_synostosis | 0.50059715 |
| 111 | MP0002098_abnormal_vibrissa_morphology | 0.48827811 |
| 112 | MP0000747_muscle_weakness | 0.48524870 |
| 113 | MP0000015_abnormal_ear_pigmentation | 0.47044111 |
| 114 | MP0000598_abnormal_liver_morphology | 0.46234393 |
| 115 | MP0000678_abnormal_parathyroid_gland | 0.45638818 |
| 116 | MP0003795_abnormal_bone_structure | 0.45598692 |
| 117 | MP0006138_congestive_heart_failure | 0.45569934 |
| 118 | MP0000371_diluted_coat_color | 0.45084556 |
| 119 | MP0005310_abnormal_salivary_gland | 0.44674894 |
| 120 | MP0002078_abnormal_glucose_homeostasis | 0.43393167 |
| 121 | MP0003953_abnormal_hormone_level | 0.43349522 |
| 122 | MP0010386_abnormal_urinary_bladder | 0.42881547 |
| 123 | * MP0008469_abnormal_protein_level | 0.42556839 |
| 124 | MP0003329_amyloid_beta_deposits | 0.42023489 |
| 125 | MP0002115_abnormal_skeleton_extremities | 0.41604184 |
| 126 | MP0005408_hypopigmentation | 0.40579332 |
| 127 | MP0004742_abnormal_vestibular_system | 0.40000357 |
| 128 | MP0005165_increased_susceptibility_to | 0.39374090 |
| 129 | MP0004484_altered_response_of | 0.39331081 |
| 130 | MP0002069_abnormal_eating/drinking_beha | 0.39212920 |
| 131 | MP0000477_abnormal_intestine_morphology | 0.38255785 |
| 132 | MP0005375_adipose_tissue_phenotype | 0.38075132 |
| 133 | MP0001873_stomach_inflammation | 0.36767738 |
| 134 | MP0003868_abnormal_feces_composition | 0.35779762 |
| 135 | MP0006035_abnormal_mitochondrial_morpho | 0.35680810 |
| 136 | MP0002998_abnormal_bone_remodeling | 0.34531336 |
| 137 | MP0005166_decreased_susceptibility_to | 0.32920410 |
| 138 | MP0004858_abnormal_nervous_system | 0.32122906 |
| 139 | MP0000163_abnormal_cartilage_morphology | 0.29782366 |
| 140 | MP0008872_abnormal_physiological_respon | 0.29730886 |
| 141 | MP0001963_abnormal_hearing_physiology | 0.29651759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 7.64662990 |
| 2 | Metabolic alkalosis (HP:0200114) | 7.63194805 |
| 3 | Hyperactive renin-angiotensin system (HP:0000841) | 7.22715735 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 7.07003653 |
| 5 | Hypomagnesemia (HP:0002917) | 7.04762399 |
| 6 | Gout (HP:0001997) | 6.64083174 |
| 7 | Abnormality of chloride homeostasis (HP:0011422) | 6.49485095 |
| 8 | Polyuria (HP:0000103) | 6.31043998 |
| 9 | Abnormality of magnesium homeostasis (HP:0004921) | 6.06844389 |
| 10 | Abnormal urine output (HP:0012590) | 6.01060250 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 5.71586206 |
| 12 | Abnormality of renal excretion (HP:0011036) | 5.71356641 |
| 13 | Chronic diarrhea (HP:0002028) | 5.39335482 |
| 14 | Proximal tubulopathy (HP:0000114) | 5.22792844 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.14182551 |
| 16 | Tetany (HP:0001281) | 5.08421251 |
| 17 | Polydipsia (HP:0001959) | 5.08031891 |
| 18 | Abnormal drinking behavior (HP:0030082) | 5.08031891 |
| 19 | Hyperuricemia (HP:0002149) | 5.00023960 |
| 20 | Increased purine levels (HP:0004368) | 5.00023960 |
| 21 | Abnormality of renin-angiotensin system (HP:0000847) | 4.94048183 |
| 22 | Hyperaldosteronism (HP:0000859) | 4.83417343 |
| 23 | Hyperglycinuria (HP:0003108) | 4.80662071 |
| 24 | Alkalosis (HP:0001948) | 4.76628355 |
| 25 | Fat malabsorption (HP:0002630) | 4.73273734 |
| 26 | Renal salt wasting (HP:0000127) | 4.66821383 |
| 27 | Acanthocytosis (HP:0001927) | 4.54404888 |
| 28 | Abnormality of purine metabolism (HP:0004352) | 4.41049280 |
| 29 | Abnormality of vitamin metabolism (HP:0100508) | 4.02602224 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 4.00310888 |
| 31 | Hypercalciuria (HP:0002150) | 3.95858536 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.91136532 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.91136532 |
| 34 | Pigmentary retinal degeneration (HP:0001146) | 3.82929765 |
| 35 | Ketoacidosis (HP:0001993) | 3.78504047 |
| 36 | Hypokalemia (HP:0002900) | 3.75734850 |
| 37 | Generalized aminoaciduria (HP:0002909) | 3.68879996 |
| 38 | Renal tubular acidosis (HP:0001947) | 3.48441129 |
| 39 | Abnormality of urine glucose concentration (HP:0011016) | 3.45875004 |
| 40 | Glycosuria (HP:0003076) | 3.45875004 |
| 41 | Wide cranial sutures (HP:0010537) | 3.44581002 |
| 42 | Abdominal distention (HP:0003270) | 3.27506241 |
| 43 | Abnormality of proline metabolism (HP:0010907) | 3.26079379 |
| 44 | Hydroxyprolinuria (HP:0003080) | 3.26079379 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 3.20446809 |
| 46 | Xanthomatosis (HP:0000991) | 3.20023196 |
| 47 | Ketosis (HP:0001946) | 3.16878003 |
| 48 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.13920787 |
| 49 | Abnormality of potassium homeostasis (HP:0011042) | 3.13620528 |
| 50 | Congenital sensorineural hearing impairment (HP:0008527) | 3.10338614 |
| 51 | Hyperphosphaturia (HP:0003109) | 3.09829048 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.98961402 |
| 53 | Steatorrhea (HP:0002570) | 2.97477452 |
| 54 | Megaloblastic anemia (HP:0001889) | 2.95892105 |
| 55 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.95046170 |
| 56 | Delayed epiphyseal ossification (HP:0002663) | 2.92700052 |
| 57 | Abnormal urine phosphate concentration (HP:0012599) | 2.90215463 |
| 58 | Nephrolithiasis (HP:0000787) | 2.87369153 |
| 59 | Posterior subcapsular cataract (HP:0007787) | 2.86776343 |
| 60 | Hypolipoproteinemia (HP:0010981) | 2.85873501 |
| 61 | Nephrocalcinosis (HP:0000121) | 2.83520382 |
| 62 | Hyperparathyroidism (HP:0000843) | 2.73119974 |
| 63 | Dehydration (HP:0001944) | 2.67610149 |
| 64 | Delayed CNS myelination (HP:0002188) | 2.65014623 |
| 65 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.64587279 |
| 66 | Villous atrophy (HP:0011473) | 2.64587279 |
| 67 | Eczematoid dermatitis (HP:0000976) | 2.59998361 |
| 68 | Hemorrhage of the eye (HP:0011885) | 2.59834737 |
| 69 | Vacuolated lymphocytes (HP:0001922) | 2.56810433 |
| 70 | Malnutrition (HP:0004395) | 2.55962994 |
| 71 | Hyperglycinemia (HP:0002154) | 2.55725038 |
| 72 | Hypophosphatemia (HP:0002148) | 2.55114428 |
| 73 | Vascular calcification (HP:0004934) | 2.54189875 |
| 74 | Widely patent fontanelles and sutures (HP:0004492) | 2.50920441 |
| 75 | Enlarged epiphyses (HP:0010580) | 2.47837371 |
| 76 | Focal segmental glomerulosclerosis (HP:0000097) | 2.44589605 |
| 77 | Abnormality of sodium homeostasis (HP:0010931) | 2.40240571 |
| 78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.39023891 |
| 79 | Dicarboxylic aciduria (HP:0003215) | 2.39023891 |
| 80 | Hyponatremia (HP:0002902) | 2.37751083 |
| 81 | Rickets (HP:0002748) | 2.37252903 |
| 82 | Hyperammonemia (HP:0001987) | 2.36646200 |
| 83 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.33343372 |
| 84 | Metabolic acidosis (HP:0001942) | 2.31353733 |
| 85 | Metaphyseal cupping (HP:0003021) | 2.30075393 |
| 86 | Right ventricular cardiomyopathy (HP:0011663) | 2.29981263 |
| 87 | Adrenal overactivity (HP:0002717) | 2.29098981 |
| 88 | Confusion (HP:0001289) | 2.28951097 |
| 89 | Cardiovascular calcification (HP:0011915) | 2.26129265 |
| 90 | Vomiting (HP:0002013) | 2.24650643 |
| 91 | Flat acetabular roof (HP:0003180) | 2.23609898 |
| 92 | Abnormal glucose tolerance (HP:0001952) | 2.18617811 |
| 93 | Epidermoid cyst (HP:0200040) | 2.18196401 |
| 94 | Subcapsular cataract (HP:0000523) | 2.16702896 |
| 95 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.15052716 |
| 96 | Hyperphosphatemia (HP:0002905) | 2.13599941 |
| 97 | Protuberant abdomen (HP:0001538) | 2.13188396 |
| 98 | Abnormal tarsal ossification (HP:0008369) | 2.11915019 |
| 99 | Facial shape deformation (HP:0011334) | 2.10497897 |
| 100 | Potter facies (HP:0002009) | 2.10497897 |
| 101 | Thin bony cortex (HP:0002753) | 2.10343872 |
| 102 | Renal tubular dysfunction (HP:0000124) | 2.08790660 |
| 103 | Enlarged kidneys (HP:0000105) | 2.08180472 |
| 104 | Abnormality of renal resorption (HP:0011038) | 2.03826369 |
| 105 | Cerebral palsy (HP:0100021) | 2.03784558 |
| 106 | Pancreatitis (HP:0001733) | 2.03719701 |
| 107 | Glomerulonephritis (HP:0000099) | 2.03105069 |
| 108 | Gingivitis (HP:0000230) | 2.00540123 |
| 109 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.00047312 |
| 110 | Gastrointestinal dysmotility (HP:0002579) | 1.99437825 |
| 111 | Tubular atrophy (HP:0000092) | 1.99117499 |
| 112 | Chondrocalcinosis (HP:0000934) | 1.97309081 |
| 113 | Lethargy (HP:0001254) | 1.96998501 |
| 114 | Poikilocytosis (HP:0004447) | 1.94824944 |
| 115 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.94423740 |
| 116 | Decreased circulating renin level (HP:0003351) | 1.94271266 |
| 117 | Methylmalonic aciduria (HP:0012120) | 1.91669553 |
| 118 | Intrahepatic cholestasis (HP:0001406) | 1.91243470 |
| 119 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.90151100 |
| 120 | Abnormality of complement system (HP:0005339) | 1.87680449 |
| 121 | Tubulointerstitial fibrosis (HP:0005576) | 1.87298581 |
| 122 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.87082231 |
| 123 | Growth hormone excess (HP:0000845) | 1.85486045 |
| 124 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.84082663 |
| 125 | Abnormality of Sharpey fibers (HP:0100685) | 1.84052264 |
| 126 | Multiple lipomas (HP:0001012) | 1.83500471 |
| 127 | Complement deficiency (HP:0004431) | 1.81450616 |
| 128 | Nephritis (HP:0000123) | 1.80227939 |
| 129 | Conjugated hyperbilirubinemia (HP:0002908) | 1.79670025 |
| 130 | Bicornuate uterus (HP:0000813) | 1.77752723 |
| 131 | Hypotension (HP:0002615) | 1.77204392 |
| 132 | Nausea (HP:0002018) | 1.76885964 |
| 133 | Abnormality of carpal bone ossification (HP:0006257) | 1.76151429 |
| 134 | Symptomatic seizures (HP:0011145) | 1.74904959 |
| 135 | Metaphyseal irregularity (HP:0003025) | 1.74681260 |
| 136 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.74557173 |
| 137 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.74156441 |
| 138 | Abnormality of the costochondral junction (HP:0000919) | 1.73340647 |
| 139 | Pili torti (HP:0003777) | 1.72748100 |
| 140 | Abnormal biliary tract morphology (HP:0012440) | 1.71430824 |
| 141 | Glomerulosclerosis (HP:0000096) | 1.68252567 |
| 142 | Irritability (HP:0000737) | 1.67208999 |
| 143 | Sensorimotor neuropathy (HP:0007141) | 1.63135100 |
| 144 | Abnormality of vitamin B metabolism (HP:0004340) | 1.60824309 |
| 145 | Late onset (HP:0003584) | 1.59228536 |
| 146 | Ileus (HP:0002595) | 1.59050369 |
| 147 | Lymphangioma (HP:0100764) | 1.58834753 |
| 148 | Tachypnea (HP:0002789) | 1.58055465 |
| 149 | Generalized muscle weakness (HP:0003324) | 1.54615063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 8.71642973 |
| 2 | WNK4 | 8.31305240 |
| 3 | ACVR1B | 8.13615683 |
| 4 | OXSR1 | 7.40832406 |
| 5 | STK39 | 3.90736026 |
| 6 | EPHA2 | 3.17622668 |
| 7 | BCKDK | 2.53483004 |
| 8 | STK38L | 2.27414585 |
| 9 | TESK2 | 2.18464204 |
| 10 | MST4 | 1.98613730 |
| 11 | PDK3 | 1.91018297 |
| 12 | PDK4 | 1.91018297 |
| 13 | NEK1 | 1.83615371 |
| 14 | WNK1 | 1.79786194 |
| 15 | MST1R | 1.75825439 |
| 16 | SGK223 | 1.67030821 |
| 17 | SGK494 | 1.67030821 |
| 18 | TYK2 | 1.63613909 |
| 19 | EPHA3 | 1.57698378 |
| 20 | PDK2 | 1.49428985 |
| 21 | MAP3K12 | 1.45493779 |
| 22 | TNIK | 1.39279993 |
| 23 | MAP4K1 | 1.29652405 |
| 24 | FRK | 1.27764152 |
| 25 | RIPK4 | 1.27725981 |
| 26 | PRPF4B | 1.20398522 |
| 27 | GRK6 | 1.16757203 |
| 28 | AKT3 | 1.13434693 |
| 29 | STK24 | 1.09991273 |
| 30 | MAP3K1 | 1.08941090 |
| 31 | STK38 | 1.08712784 |
| 32 | FGFR3 | 1.08707855 |
| 33 | EPHA4 | 1.08593240 |
| 34 | LRRK2 | 1.03007687 |
| 35 | SGK3 | 0.97185375 |
| 36 | SGK2 | 0.90767414 |
| 37 | FGFR4 | 0.90394978 |
| 38 | CDC42BPA | 0.88119280 |
| 39 | EPHB1 | 0.87840443 |
| 40 | NLK | 0.86242104 |
| 41 | PTK6 | 0.79691939 |
| 42 | RIPK1 | 0.79330190 |
| 43 | MAP3K7 | 0.73102714 |
| 44 | PTK2 | 0.72896836 |
| 45 | GSK3A | 0.68168900 |
| 46 | PRKCI | 0.68058540 |
| 47 | LMTK2 | 0.66627692 |
| 48 | MYLK | 0.64850699 |
| 49 | PINK1 | 0.62461003 |
| 50 | PRKAA1 | 0.58574949 |
| 51 | MET | 0.58096152 |
| 52 | PAK4 | 0.58085834 |
| 53 | DYRK1B | 0.56191275 |
| 54 | MAP3K3 | 0.55934320 |
| 55 | IRAK1 | 0.55148706 |
| 56 | MAP2K2 | 0.54213623 |
| 57 | ERN1 | 0.53429471 |
| 58 | SGK1 | 0.52748005 |
| 59 | CASK | 0.52507934 |
| 60 | JAK1 | 0.52183865 |
| 61 | BMPR2 | 0.51619452 |
| 62 | MAPK11 | 0.51417590 |
| 63 | PDPK1 | 0.50734106 |
| 64 | MAP3K2 | 0.49404213 |
| 65 | STK10 | 0.49075059 |
| 66 | PRKAA2 | 0.49028577 |
| 67 | TBK1 | 0.48995756 |
| 68 | RET | 0.47218286 |
| 69 | FER | 0.47188114 |
| 70 | CAMK2D | 0.45520821 |
| 71 | NME1 | 0.45191983 |
| 72 | MAP3K14 | 0.42462648 |
| 73 | TIE1 | 0.42300878 |
| 74 | FYN | 0.42179665 |
| 75 | YES1 | 0.42147229 |
| 76 | PRKG2 | 0.41534021 |
| 77 | CSF1R | 0.39555037 |
| 78 | PAK3 | 0.38867496 |
| 79 | ABL2 | 0.37878399 |
| 80 | EPHB2 | 0.35576528 |
| 81 | IKBKE | 0.33695951 |
| 82 | PDK1 | 0.33468973 |
| 83 | TGFBR2 | 0.32594057 |
| 84 | INSRR | 0.32322071 |
| 85 | STK11 | 0.32172773 |
| 86 | ZAP70 | 0.32038979 |
| 87 | NEK6 | 0.31030453 |
| 88 | CAMK2G | 0.29224090 |
| 89 | CDK19 | 0.29167294 |
| 90 | CDK6 | 0.29082586 |
| 91 | SMG1 | 0.28480127 |
| 92 | BTK | 0.27981489 |
| 93 | PRKCZ | 0.27687187 |
| 94 | GRK1 | 0.26541430 |
| 95 | SYK | 0.25989268 |
| 96 | PRKCD | 0.25879096 |
| 97 | CAMK2B | 0.25219354 |
| 98 | MELK | 0.24530920 |
| 99 | LATS1 | 0.24059720 |
| 100 | PRKD2 | 0.23555533 |
| 101 | PTK2B | 0.22553321 |
| 102 | PIK3CG | 0.22293951 |
| 103 | MAPKAPK2 | 0.22088554 |
| 104 | NTRK1 | 0.21926468 |
| 105 | LYN | 0.21247268 |
| 106 | JAK3 | 0.21118934 |
| 107 | TAOK1 | 0.21008079 |
| 108 | PRKACG | 0.20824738 |
| 109 | TEC | 0.20369130 |
| 110 | TRIB3 | 0.20099104 |
| 111 | MAP3K11 | 0.18673017 |
| 112 | LCK | 0.18544211 |
| 113 | RPS6KA2 | 0.18334402 |
| 114 | BMX | 0.17992255 |
| 115 | DAPK2 | 0.17909124 |
| 116 | TESK1 | 0.17742051 |
| 117 | PRKCA | 0.17303333 |
| 118 | DDR2 | 0.17121202 |
| 119 | SCYL2 | 0.16917798 |
| 120 | JAK2 | 0.16494788 |
| 121 | AKT2 | 0.14812534 |
| 122 | PIM1 | 0.13303088 |
| 123 | MATK | 0.13004488 |
| 124 | ERBB4 | 0.12690390 |
| 125 | KSR2 | 0.12244194 |
| 126 | ITK | 0.11582620 |
| 127 | MAP2K1 | 0.10668128 |
| 128 | ERBB2 | 0.10447806 |
| 129 | ROCK1 | 0.08924319 |
| 130 | SRC | 0.07897134 |
| 131 | PRKACA | 0.07592763 |
| 132 | TTK | 0.06434672 |
| 133 | MAPK15 | 0.06344428 |
| 134 | PIK3CA | 0.06275499 |
| 135 | PDGFRA | 0.05227493 |
| 136 | CSK | 0.04963069 |
| 137 | MAP2K3 | 0.04956954 |
| 138 | PRKCQ | 0.03915518 |
| 139 | MAP3K8 | 0.03243899 |
| 140 | PRKCH | 0.03165696 |
| 141 | INSR | 0.02967506 |
| 142 | CSNK1A1 | 0.02550586 |
| 143 | MAP2K6 | 0.02095583 |
| 144 | IRAK3 | 0.01843721 |
| 145 | MINK1 | 0.00851148 |
| 146 | MAP3K10 | 0.00566429 |
| 147 | IGF1R | 0.00565431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.62852006 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.60924436 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.45815059 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.40948326 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.12368634 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.07032180 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.05685993 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.97886476 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.95038868 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.73921111 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.41093357 |
| 12 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.35545020 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.35342098 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.33778717 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.33217587 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31012301 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.27292293 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.27152642 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 2.04177699 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.91101835 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.87972490 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85809284 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.84108227 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.78653812 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.76807177 |
| 26 | Mineral absorption_Homo sapiens_hsa04978 | 1.73713044 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.65644688 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64694994 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.62247423 |
| 30 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.61874199 |
| 31 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.47320553 |
| 32 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.43369005 |
| 33 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.41096378 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.38393264 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.37344496 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.32386254 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.27551999 |
| 38 | Lysine degradation_Homo sapiens_hsa00310 | 1.26439956 |
| 39 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 1.25860860 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21733168 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20038281 |
| 42 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.19907416 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18058111 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.15628445 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12289240 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.06767165 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02616498 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.01744680 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01341099 |
| 50 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00085980 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99130321 |
| 52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96853489 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.94417520 |
| 54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93341052 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87987561 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86296917 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82860315 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82345308 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 0.79868733 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78117775 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.74390918 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73922639 |
| 63 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.70257949 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67640215 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65516385 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.64732732 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63232011 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61290407 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61109425 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60349054 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57894994 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53592608 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.53563251 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52094252 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52033289 |
| 76 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50699170 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.46848545 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.46198287 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44015148 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.41104385 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39514829 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39088869 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.36185723 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.33845979 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33561455 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.33460798 |
| 87 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.33449676 |
| 88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33434227 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.33198196 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.33054872 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31841881 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31531136 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30812641 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.27041293 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26913156 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23048984 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23011734 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20975123 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20834141 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.20830694 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.20557016 |
| 102 | Cocaine addiction_Homo sapiens_hsa05030 | 0.20294732 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18534603 |
| 104 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.14512217 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.13431171 |
| 106 | Viral myocarditis_Homo sapiens_hsa05416 | 0.12287090 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.11363503 |
| 108 | Insulin secretion_Homo sapiens_hsa04911 | 0.10103005 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.09857303 |
| 110 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.09556641 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.09386878 |
| 112 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.09100923 |
| 113 | Alzheimers disease_Homo sapiens_hsa05010 | 0.09035731 |
| 114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.08669667 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08230411 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.07561089 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.07267087 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.07036371 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.06980623 |
| 120 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.06901892 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.06119856 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.05918539 |
| 123 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.05316453 |
| 124 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.04472632 |
| 125 | Tight junction_Homo sapiens_hsa04530 | 0.04231113 |
| 126 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.03332914 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.03264365 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.02962233 |
| 129 | Hepatitis C_Homo sapiens_hsa05160 | 0.02636539 |
| 130 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.00569403 |

